NOVARTIS INDIA LTD.
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹732
- Today's High:
- ₹760
- Open Price:
- ₹760
- 52W Low:
- ₹524.8776
- 52W High:
- ₹861.8
- Prev. Close:
- ₹750.9
- Volume:
- 1513
Company Statistics
- Market Cap.:
- ₹21.73 billion
- Book Value:
- 314.149
- Revenue TTM:
- ₹3.79 billion
- Operating Margin TTM:
- 15.86%
- Gross Profit TTM:
- ₹2.56 billion
- Profit Margin:
- 27.29%
- Return on Assets TTM:
- 3.87%
- Return on Equity TTM:
- 14.09%
Company Profile
NOVARTIS INDIA LTD. had its IPO on under the ticker symbol NOVARTIND.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. NOVARTIS INDIA LTD. has a staff strength of 67 employees.
Stock update
Shares of NOVARTIS INDIA LTD. opened at ₹760 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹732 - ₹760, and closed at ₹747.55.
This is a -0.45% slip from the previous day's closing price.
A total volume of 1,513 shares were traded at the close of the day’s session.
In the last one week, shares of NOVARTIS INDIA LTD. have increased by +4.55%.
NOVARTIS INDIA LTD.'s Key Ratios
NOVARTIS INDIA LTD. has a market cap of ₹21.73 billion, indicating a price to book ratio of 2.2561 and a price to sales ratio of 4.0924.
In the last 12-months NOVARTIS INDIA LTD.’s revenue was ₹3.79 billion with a gross profit of ₹2.56 billion and an EBITDA of ₹618.40 million. The EBITDA ratio measures NOVARTIS INDIA LTD.'s overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, NOVARTIS INDIA LTD.’s operating margin was 15.86% while its return on assets stood at 3.87% with a return of equity of 14.09%.
In Q1, NOVARTIS INDIA LTD.’s quarterly earnings growth was a positive 0% while revenue growth was a negative 22.6%.
NOVARTIS INDIA LTD.’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 21.0291
- PEG
Its diluted EPS in the last 12-months stands at ₹38.48 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into NOVARTIS INDIA LTD.’s profitability.
NOVARTIS INDIA LTD. stock is trading at a EV to sales ratio of 2.7329 and a EV to EBITDA ratio of 17.2923. Its price to sales ratio in the trailing 12-months stood at 4.0924.
NOVARTIS INDIA LTD. stock pays annual dividends of ₹10 per share, indicating a yield of 1.11% and a payout ratio of 113.47%.
Balance sheet and cash flow metrics
- Total Assets
- ₹9.83 billion
- Total Liabilities
- ₹1.59 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 113.47%
NOVARTIS INDIA LTD. ended 2024 with ₹9.83 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹9.83 billion while shareholder equity stood at ₹7.76 billion.
NOVARTIS INDIA LTD. ended 2024 with ₹0 in deferred long-term liabilities, ₹1.59 billion in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹194.20 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.
NOVARTIS INDIA LTD.’s total current assets stands at ₹6.77 billion while long-term investments were ₹0 and short-term investments were ₹5.50 billion. Its net receivables were ₹361.60 million compared to accounts payable of ₹596.70 million and inventory worth ₹547.20 million.
In 2024, NOVARTIS INDIA LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, NOVARTIS INDIA LTD. paid ₹1.13 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹747.55
- 52-Week High
- ₹861.8
- 52-Week Low
- ₹524.8776
- Analyst Target Price
- ₹
NOVARTIS INDIA LTD. stock is currently trading at ₹747.55 per share. It touched a 52-week high of ₹861.8 and a 52-week low of ₹861.8. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹756.49 and 200-day moving average was ₹660.74 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 7277.6% of the company’s stock are held by insiders while 14% are held by institutions.
Frequently Asked Questions About NOVARTIS INDIA LTD.
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
Novartis India Limited operates as a healthcare company in India. It offers pharmaceutical products in the areas of bone and pain, calcium portfolio, gynecology, and neurosciences, as well as generics products in the areas of gynecology, anti-TB, and anti-infectives. The company provides central nervous system products under the Tegrital and Exelon brands; pain and inflammation products under the Voveran brand; and transplantation/immunology products under the Simulect, Certican, Myfortic, and Sandimmun Neoral brands. The company was incorporated in 1947 and is headquartered in Mumbai, India. Novartis India Limited is a subsidiary of Novartis AG.